These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 11226328)

  • 1. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.
    Reyes TM; Lewis K; Perrin MH; Kunitake KS; Vaughan J; Arias CA; Hogenesch JB; Gulyas J; Rivier J; Vale WW; Sawchenko PE
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2843-8. PubMed ID: 11226328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
    Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
    Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
    Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.
    Bittencourt JC; Vaughan J; Arias C; Rissman RA; Vale WW; Sawchenko PE
    J Comp Neurol; 1999 Dec; 415(3):285-312. PubMed ID: 10553117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system.
    Bittencourt JC; Sawchenko PE
    J Neurosci; 2000 Feb; 20(3):1142-56. PubMed ID: 10648719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.
    Kimura Y; Takahashi K; Totsune K; Muramatsu Y; Kaneko C; Darnel AD; Suzuki T; Ebina M; Nukiwa T; Sasano H
    J Clin Endocrinol Metab; 2002 Jan; 87(1):340-6. PubMed ID: 11788672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids.
    Chen A; Perrin M; Brar B; Li C; Jamieson P; Digruccio M; Lewis K; Vale W
    Mol Endocrinol; 2005 Feb; 19(2):441-58. PubMed ID: 15514029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA expression of corticotropin-releasing factor and urocortin 1 after restraint and foot shock together with alprazolam administration.
    Cespedes IC; de Oliveira AR; da Silva JM; da Silva AV; Sita LV; Bittencourt JC
    Peptides; 2010 Dec; 31(12):2200-8. PubMed ID: 20833218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurobiology of urocortin.
    Skelton KH; Owens MJ; Nemeroff CB
    Regul Pept; 2000 Sep; 93(1-3):85-92. PubMed ID: 11033056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
    Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
    Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urocortin 2 expression in the rat gastrointestinal tract under basal conditions and in chemical colitis.
    Chang J; Hoy JJ; Idumalla PS; Clifton MS; Pecoraro NC; Bhargava A
    Peptides; 2007 Jul; 28(7):1453-60. PubMed ID: 17586086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways.
    Chen A; Vaughan J; Vale WW
    Mol Endocrinol; 2003 Aug; 17(8):1622-39. PubMed ID: 12764078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
    Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation.
    Inada Y; Ikeda K; Tojo K; Sakamoto M; Takada Y; Tajima N
    Peptides; 2009 Feb; 30(2):365-72. PubMed ID: 19026699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues.
    Baigent SM; Lowry PJ
    J Mol Endocrinol; 2000 Aug; 25(1):43-52. PubMed ID: 10915217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microinjection of urocortin into the rat nucleus tractus solitarii decreases arterial blood pressure.
    Yamazaki T; Waki H; Kohsaka A; Nakamura T; Cui H; Yukawa K; Maeda M
    Auton Neurosci; 2008 Nov; 142(1-2):51-4. PubMed ID: 18804421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of human urocortin.
    Donaldson CJ; Sutton SW; Perrin MH; Corrigan AZ; Lewis KA; Rivier JE; Vaughan JM; Vale WW
    Endocrinology; 1996 May; 137(5):2167-70. PubMed ID: 8612563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression.
    Li C; Vaughan J; Sawchenko PE; Vale WW
    J Neurosci; 2002 Feb; 22(3):991-1001. PubMed ID: 11826127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides.
    Brar BK; Chen A; Perrin MH; Vale W
    Endocrinology; 2004 Apr; 145(4):1718-29. PubMed ID: 14670995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids.
    Chen A; Blount A; Vaughan J; Brar B; Vale W
    Endocrinology; 2004 May; 145(5):2445-57. PubMed ID: 14736736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.